Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 14 studies | 34% ± 15% | |
| endothelial cell | 12 studies | 26% ± 11% | |
| basal cell | 9 studies | 27% ± 13% | |
| endothelial cell of artery | 7 studies | 25% ± 5% | |
| capillary endothelial cell | 5 studies | 20% ± 4% | |
| epithelial cell | 5 studies | 37% ± 15% | |
| type II pneumocyte | 5 studies | 26% ± 12% | |
| enterocyte | 4 studies | 20% ± 2% | |
| endothelial cell of vascular tree | 4 studies | 17% ± 1% | |
| conventional dendritic cell | 3 studies | 25% ± 9% | |
| epithelial cell of proximal tubule | 3 studies | 19% ± 3% | |
| vein endothelial cell | 3 studies | 16% ± 1% | |
| type I pneumocyte | 3 studies | 31% ± 7% | |
| macrophage | 3 studies | 30% ± 6% | |
| dendritic cell | 3 studies | 21% ± 2% | |
| enteroendocrine cell | 3 studies | 32% ± 15% | |
| mast cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 4 studies | 23% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 966.36 | 328 / 328 | 100% | 34.74 | 178 / 178 |
| thymus | 100% | 1192.92 | 653 / 653 | 100% | 60.23 | 605 / 605 |
| kidney | 100% | 1183.79 | 89 / 89 | 99% | 34.67 | 892 / 901 |
| prostate | 99% | 997.89 | 243 / 245 | 99% | 48.69 | 498 / 502 |
| lung | 100% | 985.91 | 577 / 578 | 97% | 39.54 | 1122 / 1155 |
| breast | 100% | 854.57 | 459 / 459 | 96% | 26.88 | 1071 / 1118 |
| uterus | 96% | 354.36 | 164 / 170 | 98% | 40.62 | 450 / 459 |
| stomach | 96% | 562.09 | 343 / 359 | 98% | 37.60 | 281 / 286 |
| ovary | 94% | 311.47 | 169 / 180 | 100% | 47.77 | 429 / 430 |
| adrenal gland | 100% | 858.34 | 258 / 258 | 93% | 23.36 | 214 / 230 |
| intestine | 91% | 526.61 | 882 / 966 | 99% | 44.56 | 523 / 527 |
| skin | 92% | 457.19 | 1672 / 1809 | 97% | 34.16 | 460 / 472 |
| esophagus | 92% | 402.75 | 1329 / 1445 | 96% | 22.72 | 175 / 183 |
| liver | 99% | 408.13 | 223 / 226 | 88% | 24.18 | 356 / 406 |
| brain | 97% | 1036.12 | 2563 / 2642 | 85% | 17.27 | 600 / 705 |
| bladder | 71% | 420.29 | 15 / 21 | 97% | 39.65 | 490 / 504 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 28.64 | 29 / 29 |
| spleen | 100% | 624.83 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 32.79 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 33.38 | 1 / 1 |
| adipose | 100% | 671.04 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 99% | 650.73 | 856 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 644.41 | 795 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 83.79 | 79 / 80 |
| blood vessel | 68% | 191.36 | 911 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 64% | 169.33 | 597 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006753 | Biological process | nucleoside phosphate metabolic process |
| GO_0019693 | Biological process | ribose phosphate metabolic process |
| GO_0018279 | Biological process | protein N-linked glycosylation via asparagine |
| GO_0005829 | Cellular component | cytosol |
| GO_0047631 | Molecular function | ADP-ribose diphosphatase activity |
| GO_0008768 | Molecular function | UDP-sugar diphosphatase activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | NUDT14 |
| Protein name | Nudix (Nucleoside diphosphate linked moiety X)-type motif 14, isoform CRA_a (cDNA FLJ46324 fis, clone TESTI4043223, highly similar to Uridine diphosphate glucose pyrophosphatase (EC 3.6.1.45)) Uridine diphosphate glucose pyrophosphatase NUDT14 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 14) (Nudix motif 14) Nudix hydrolase 14 |
| Synonyms | UGPP hCG_19132 |
| Description | FUNCTION: Hydrolyzes UDP-glucose to glucose 1-phosphate and UMP and ADP-ribose to ribose 5-phosphate and AMP. The physiological substrate is probably UDP-glucose. Poor activity on other substrates such as ADP-glucose, CDP-glucose, GDP-glucose and GDP-mannose. |
| Accessions | F8VU44 ENST00000546553.1 ENST00000392568.7 B3KXY7 O95848 |